POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 90 filers reported holding POSEIDA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,279,520 | +37.7% | 2,638,454 | +1.8% | 0.00% | – |
| Q2 2023 | $4,560,510 | -37.3% | 2,591,199 | +9.8% | 0.00% | – |
| Q1 2023 | $7,271,116 | -41.2% | 2,360,752 | +1.3% | 0.00% | – |
| Q4 2022 | $12,355,922 | +46.8% | 2,331,306 | -2.2% | 0.00% | – |
| Q3 2022 | $8,419,000 | +146.2% | 2,384,866 | +79.9% | 0.00% | – |
| Q2 2022 | $3,420,000 | -47.2% | 1,325,650 | -8.3% | 0.00% | – |
| Q1 2022 | $6,479,000 | -34.5% | 1,446,264 | -0.4% | 0.00% | – |
| Q4 2021 | $9,889,000 | -10.5% | 1,452,155 | -4.2% | 0.00% | – |
| Q3 2021 | $11,046,000 | -17.1% | 1,515,194 | +13.9% | 0.00% | – |
| Q2 2021 | $13,331,000 | -2.9% | 1,330,451 | -7.4% | 0.00% | – |
| Q1 2021 | $13,727,000 | +112.8% | 1,437,334 | +144.4% | 0.00% | – |
| Q4 2020 | $6,452,000 | +28.3% | 588,089 | +3.7% | 0.00% | – |
| Q3 2020 | $5,030,000 | – | 566,951 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,043,267 | $9,254,000 | 2.96% |
| SECTORAL ASSET MANAGEMENT INC | 1,053,779 | $9,347,000 | 0.80% |
| Pentwater Capital Management LP | 4,879,490 | $43,281,000 | 0.56% |
| Vivo Capital, LLC | 926,449 | $8,218,000 | 0.48% |
| Boxer Capital, LLC | 1,251,055 | $11,097,000 | 0.38% |
| Ikarian Capital, LLC | 228,000 | $2,022,000 | 0.15% |
| Perceptive Advisors | 787,745 | $6,987,000 | 0.10% |
| Rock Springs Capital Management LP | 367,499 | $3,260,000 | 0.08% |
| PURA VIDA INVESTMENTS, LLC | 148,949 | $1,321,000 | 0.07% |
| PIPER SANDLER & CO. | 8,298 | $74,000 | 0.06% |